Back to results

CompletedPhase 3

Agitation in Alzheimer's Disease

NCT00000179

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California, Los Angeles

Los Angeles, California, United States

+15 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Sponsor: National Institute on Aging (NIA)
Purpose: treatment

Locations (16)

University of California, Los AngelesLos Angeles, California, United States
University of California, San DiegoSan Diego, California, United States
University of MiamiMiami, Florida, United States
University of South FloridaTampa, Florida, United States
Emory UniversityAtlanta, Georgia, United States
Southern Illinois UniversitySpringfield, Illinois, United States
University of Kansas Medical CenterKansas City, Kansas, United States
University of KentuckyLexington, Kentucky, United States
University of MassachusettsWorcester, Massachusetts, United States
University of MichiganAnn Arbor, Michigan, United States
University of MinnesotaMinneapolis, Minnesota, United States
New York University Medical CenterNew York, New York, United States
Mount Sinai Medical CenterNew York, New York, United States
University of RochesterRochester, New York, United States
University Hospitals of ClevelandCleveland, Ohio, United States
Oregon Health Sciences UniversityPortland, Oregon, United States

Agitation in Alzheimer's Disease — TrialFind